liraglutide glp 1 agonist Cardiovascular Protection with a Long-Acting GLP-1 Receptor Liraglutide: An Experimental Update GLP-1 analogs, new trend in

Graphical abstract Similar content being viewed by others Introduction Glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP) are among the main incretin hormones [1]

Effects on pancreatic -cell glucagon release In addition to their insulinotropic effects on -cells, both GIP and GLP-1 play a role in regulating glucagon secretion of pancreatic -cells, with GIP increasing and GLP-1 suppressing glucagon secretion, both in a glucose-dependent manner

Discoveries of GIP and GLP-1 The first incretin, GIP, was purified from canine intestinal extracts in the late 1960s (8) and initially named gastric inhibitory polypeptide (9) because the peptide inhibited gastrin-stimulated H + secretion (10)

In FIGHT, there was no significant effect of liraglutide on 6-min walk test (6MWT) distances compared with placebo

GLP-1 RAs are known to have a beneficial effect on lipid profile and blood pressure (BP)